Intelligence Profile
Research Papers
Papers on VEGF Plasmid
Research on VEGF plasmids has explored their potential in various therapeutic areas, primarily focusing on angiogenesis and bone healing.
Bone-Targeted Delivery for Osteoporosis: A study published in the International Journal of Pharmaceutics examined the use of GLG1-modified PLGA nanoparticles to deliver VEGF and BMP2 plasmids for osteoporosis therapy. The use of these plasmids aimed to enhance bone regeneration, although specifics on the study's sample size or results were not detailed.
Gene Delivery Systems: The journal Biomedical Materials reported on the development of core-shell fibrous threads for sustained VEGF plasmid delivery. These threads offer controlled gene release, potentially improving therapeutic outcomes in regenerative medicine. Again, detailed outcomes or sample specifics were not available.
Angiogenic Gene Therapy for Ischemia: In a review published in Cells, researchers discussed advancements in angiogenic gene therapy for treating lower extremity ischemia. VEGF plasmids play a critical role in promoting blood vessel growth, although specific study designs or sizes were not mentioned.
Polymeric Gene Delivery in Oncogenic Pathways: An article in ACS Biomaterials Science & Engineering explored polymeric gene delivery systems targeting cancer pathways. While not exclusively focused on VEGF, these systems can include VEGF plasmids as part of broader therapeutic strategies.
Overall, these studies highlight the diverse potential applications of VEGF plasmids, though specific clinical outcomes frequently remain insufficiently detailed. More extensive trials could provide clearer evidence of their efficacy and safety in various medical conditions.
Disclaimer
This summary is for informational purposes only and does not constitute medical advice. For personalized medical guidance, please consult a healthcare professional.